【24h】

Cholesterol health

机译:胆固醇健康

获取原文
获取原文并翻译 | 示例
           

摘要

THE Pharmaceutical Benefits Advisory Commission (PBAC) recently redefined cholesterol target levels for patients on statin or fib-rate therapy, taking into consideration the absolute risk of cardiovascular disease in patients including those with existing risk factors.Patients with symptomatic coronary, cerebrovascular or peripheral vascular disease, diabetic patients with microal-binuria, diabetes in Aboriginal or Torres Strait Islander people, others with diabetes older than 60 years, or those patients with a strong family history of coronary heart disease, may commence cholesterol lowering therapies at any cholesterol level.According to Professor Iioyd Sansom, chair of the PBAC, these patients have a high risk of future cardiovascular events and any reduction is likely to be clinically important.
机译:药物益处咨询委员会(PBAC)最近重新定义了他汀类药物或fib-rate治疗患者的胆固醇目标水平,同时考虑了包括现有危险因素在内的患者发生心血管疾病的绝对风险。有症状的冠状动脉,脑血管或外周血管患者疾病,糖尿病患者的微蛋白尿症,原住民或托雷斯海峡岛民的糖尿病,其他60岁以上的糖尿病患者或患有冠心病家族史的患者可以在任何胆固醇水平上开始降低胆固醇的疗法。根据PBAC主席Iioyd Sansom教授的说法,这些患者未来发生心血管事件的风险很高,任何降低的剂量在临床上很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号